Catalyst
Slingshot members are tracking this event:
Portola (PTLA) Expects CHMP Opinion in Q1 2018 for Andexxa (Andexanet Alfa) in Treatment of Serious Uncontrolled Bleeding Events
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTLA |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 20, 2018
Occurred Source:
http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=2333529
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Chmp, Andexxa, Andexanet Alfa, Serious Uncontrolled Bleeding Event, Urgent, Emergent Surgery
